Skip to main content

TMO Thermo Fisher Scientific Inc.

Healthcare

697.00 Close 10/30
Since 2024-12-02 +32.4%
Open
710.69
High
711.79
Low
691.74
Prev close
709.18
Volume
2.1M
Amplitude
2.83%
P/E
36.8
P/B
4.7
Revenue YoY (TTM)
+8.3%
52W 435.27 711.85

Is Thermo Fisher Scientific Inc. a buy? Fundamentals and valuation first

As of 2026-10-30

Quality: Good, Growth: Good, Momentum: Strong, Risk / liquidity: Strong; Valuation: Pricey.

Valuation Pricey Free-cash-flow yield is Good, but Price / book is Expensive.
TTM P/E 36.76 75th percentile Pricey
Price / book 4.72 81th percentile Expensive
Free-cash-flow yield (%) 2.94 58th percentile Good
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Good All 3 indicators are Good.
ROE, TTM (%) 12.93 72th percentile Good
Operating margin, TTM (%) 17.98 69th percentile Good
FCF margin, TTM (%) 16.04 71th percentile Good
Quality Factor Investing: A US Quality Value Backtest
Growth Good All 2 indicators are Good.
Revenue growth, TTM YoY (%) 8.27 57th percentile Good
Diluted EPS growth, TTM YoY (%) 9.53 61th percentile Good
Momentum Strong 60-day return is Top; 240-day return is Good.
60-day return (%) 20.26 92th percentile Top
240-day return (%) 20.86 72th percentile Good
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Strong 20-day dollar volume is Top; 60-day annualized volatility is Good.
20-day dollar volume 1,609,499,823 99th percentile Top
60-day annualized volatility (%) 25.62 29th percentile Good
Factor Investing Explained: 10 Classic Factors in US Stocks

Thermo Fisher Scientific Inc. (TMO) today

2 quant signals active · As of 2026-10-30

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

FinLab Studio

From Thermo Fisher Scientific Inc. to every stock like it

AI finds several complementary traits of Thermo Fisher Scientific Inc. across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. (TMO) peers and tracking

Watchlist

This page refreshes daily after the close. Add Thermo Fisher Scientific Inc. to your watchlist to track signal changes on your next visit.

Thermo Fisher Scientific Inc. (TMO) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

52-week adjusted-price high

Active

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

24 historical occurrences (since 2017-03-01)

Average forward return after 52-week adjusted-price high

20-day: Win 58.3%, Sample 24, Median +1.53%, Excess -0.52%, Beat mkt rate 45.8%

60-day: Win 65.2%, Sample 23, Median +3.8%, Excess -0.08%, Beat mkt rate 60.9%

120-day: Win 78.3%, Sample 23, Median +9.07%, Excess +1.47%, Beat mkt rate 69.6%

120 days after: historical avg +5.5%

20-day +0.55%
60-day +1.64%
120-day +5.5%
20-day
60-day
120-day
Win
58.3%
65.2%
78.3%
Sample
24
23
23
Median
+1.53%
+3.8%
+9.07%
Excess
-0.52%
-0.08%
+1.47%
Beat mkt rate
45.8%
60.9%
69.6%

Over 23 occurrences, 120-day forward avg gained 5.5%, beat the market by 1.47 pts; win rate 78.3%.

Top-quintile 6-month momentum

Active · now 91.09%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

Momentum Trading Strategy: A 12-1 Momentum Backtest
14 historical occurrences (since 2017-06-09)

Average forward return after Top-quintile 6-month momentum

20-day: Win 57.1%, Sample 14, Median +1.11%, Excess -0.7%, Beat mkt rate 42.9%

60-day: Win 69.2%, Sample 13, Median +6.09%, Excess -1.91%, Beat mkt rate 46.2%

120-day: Win 61.5%, Sample 13, Median +5.53%, Excess -4.29%, Beat mkt rate 46.2%

120 days after: historical avg +4.77%

20-day +1.03%
60-day +3.5%
120-day +4.77%
20-day
60-day
120-day
Win
57.1%
69.2%
61.5%
Sample
14
13
13
Median
+1.11%
+6.09%
+5.53%
Excess
-0.7%
-1.91%
-4.29%
Beat mkt rate
42.9%
46.2%
46.2%

Over 13 occurrences, 120-day forward avg gained 4.77%, lagged the market by 4.29 pts; win rate 61.5%.

Valuation regime and forward returns

Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 411+13.1% +12.9% 86.6% -4.1%
20-40 360+1.3% +1% 55.6% -9.4%
40-60 195-7.6% -6.6% 17.9% -16.8%
60-80 You are here131-19.5% -20.4% 2.3% -24.8%
80-100 37-19.6% -18.2% 0% -9.3%

Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.

Current TTM P/E is about 36.76, placing it in the 67.6 own-history percentile, inside the 60-80 bucket.

More history: Valuation × momentum analogs, Market-wide momentum baseline, Signals not active now

Valuation × momentum analogs

Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.

Valuation
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
+4.7%
Win rate 55.9% Excess -2.4%
272d
-4.7%
Win rate 31.5% Excess -10.4%
273d
Now
-12.3%
Win rate 3.4% Excess -9.7%
118d
60-day momentum down
+11%
Win rate 67.4% Excess +2.5%
478d
-9.4%
Win rate 11.2% Excess -7.9%
107d
Insufficient data
(6d)

Currently in “Expensive (own-history top third) × 60-day momentum up”: across 118 historical days, 120-day forward avg declined 12.3%, win rate 3.4%, lagged the market by 9.7%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Market-wide momentum baseline

Across 99,493 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.42%, a 58.4% positive-return rate, and +3.08 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

PEAD: Post-Earnings Announcement Drift Backtest

13 times historically; 60-day forward avg +4.55%, win rate 61.5%, beating the market by +1.64 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.